Klas G. Wiman

Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound

Vladimir J.N. Bykov, Natalia Issaeva, Alexandre Shilov et al. · Nature Medicine · 2002 · 1.1K citations

Tumor Biology, Medicine, Molecular Biology +9

PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain

Jérémy Lambert, Petr Gorzov, Dmitry B. Veprintsev et al. · Cancer Cell · 2009 · 566 citations

Covalent Binding, Core Domain, Cell Death +6

Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer

Sören Lehmann, Vladimir J.N. Bykov, Dina Ali et al. · Journal of Clinical Oncology · 2012 · 397 citations · Full text

Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain

Galina Selivanova, Violetta Iotsova, İsmail Okan et al. · Nature Medicine · 1997 · 347 citations

Mutant P53, Tumor Biology, Medicine +8

Complete amino acid sequence of an HLA-DR antigen-like beta chain as predicted from the nucleotide sequence: similarities with immunoglobulins and HLA-A, -B, and -C antigens.

Dan Larhammar, L. Schenning, Kenth Gustafsson et al. · Proceedings of the National Academy of Sciences · 1982 · 322 citations · Full text

Histocompatibility, Hla, Genetics +22